ODI Pharma AB: Publication of interim report Q1 2022/2023
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its interim report concerning the period July 2022 to September 2022. The report...
News
Please find below news from ODI Pharma AB. More stock relevant news can be found in the section "Stock Information" on the "INVESTORS" site.
Suche
ODI Pharma
- 25. Nov.
- 1 Min.
ODI Pharma AB publishes the annual report for the fiscal year 2021/2022
The Board of Directors and the Chief Executive Officer of ODI Pharma AB (“ODI Pharma”) hereby publishes the annual report for the fiscal...
ODI Pharma
- 25. Nov.
- 1 Min.
ODI Pharma AB publicerar årsredovisning för räkenskapsåret 2021/2022
Styrelsen och verkställande direktören för ODI Pharma AB (”ODI Pharma”) publicerar härmed årsredovisningen för räkenskapsåret 2021/2022....
ODI Pharma
- 24. Nov.
- 1 Min.
ODI Pharma AB postpones publication of interim report and annual report until November 25, 2022
ODI Pharma AB (“ODI” or the “Company”) stated in its year-end report that the interim report for the first quarter of 2022/2023 and the...
ODI Pharma
- 15. Nov.
- 5 Min.
Notice to Annual General Meeting in ODI Pharma AB (publ)
This is an unofficial translation of a notice to the Annual General Meeting in ODI Pharma AB (publ), originally drafted in Swedish. In...
ODI Pharma
- 15. Nov.
- 4 Min.
Kallelse till årsstämma i ODI Pharma AB (publ)
Aktieägarna i ODI Pharma AB (publ), 559223–1392, kallas härmed till årsstämma fredagen den 16 december 2022 kl. 10.30 i bolagets lokaler...
ODI Pharma
- 25. Aug.
- 4 Min.
ODI Pharma AB: Publication of year-end report for the fiscal year 2021/2022
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its year-end report for the period July 2021 – June 2022. The report is available...
ODI Pharma
- 25. Mai
- 3 Min.
ODI Pharma AB: Publication of interim report Q3 2021/2022
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its interim report for the period July 2021 – March 2022. The report is available...
ODI Pharma
- 25. Feb.
- 4 Min.
Correction: ODI Pharma AB: Publication of half-year report 2021
Correction: ODI Pharma hereby discloses a revised half-year report for the period July – December 2021. In the previous report, the cost...
ODI Pharma
- 24. Feb.
- 4 Min.
ODI Pharma AB: Publication of half-year report 2021
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its half-year report for the period July – December 2021. The report is available...
ODI Pharma
- 13. Dez. 2021
- 2 Min.
Announcement from the Annual General Meeting in ODI Pharma AB (publ)
This is an unofficial translation of a notice to the Annual General Meeting in ODI Pharma AB (publ), originally drafted in Swedish. In...
ODI Pharma
- 13. Dez. 2021
- 2 Min.
Kommuniké från årsstämma i ODI Pharma AB (publ)
Idag den 13 december 2021 hölls årsstämma i ODI Pharma AB (publ). Nedan följer en sammanfattning av de beslut som fattades. Samtliga...
ODI Pharma
- 25. Nov. 2021
- 3 Min.
ODI Pharma AB: Publication of interim report for the first quarter 2021/2022
ODI Pharma AB (“ODI Pharma” or the “Company”) hereby publishes its interim report concerning the period July 2021 – September 2021. The...
ODI Pharma
- 18. Nov. 2021
- 1 Min.
ODI Pharma AB publishes the annual report for the fiscal year 2020/2021
The Board of Directors and the Chief Executive Officer of ODI Pharma AB (“ODI Pharma”) hereby publishes the annual report for the fiscal...
ODI Pharma
- 9. Nov. 2021
- 4 Min.
Notice to Annual General Meeting in ODI Pharma AB (publ)
This is an unofficial translation of a notice to the Annual General Meeting in ODI Pharma AB (publ), originally drafted in Swedish. In...
ODI Pharma
- 9. Nov. 2021
- 4 Min.
Kallelse till årsstämma i ODI Pharma AB (publ)
Aktieägarna i ODI Pharma AB (publ), 559223–1392, kallas härmed till årsstämma måndagen den 13 december 2021 kl. 10.00 i bolagets lokaler...
ODI Pharma
- 28. Sept. 2021
- 2 Min.
ODI Pharma AB announces the date of official launch of kandol.
ODI Pharma AB (“ODI” or the “Company”) hereby announces that kandol., the CBD skincare product line, will be officially launched as of...
ODI Pharma
- 26. Aug. 2021
- 4 Min.
ODI Pharma AB: Publication of year-end report for the financial year 2020/2021
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its year-end report for the fourth quarter and financial year 1st of July 2020 –...
ODI Pharma
- 17. Aug. 2021
- 3 Min.
ODI Pharma AB approves the official launch of kandol., an exclusive CBD infused skincare line
ODI Pharma AB (“ODI Pharma” or the “Company”), a producer and representative of finished pharmaceutical cannabis and cosmetics products,...
ODI Pharma
- 9. Juli 2021
- 2 Min.
ODI Pharma AB: Flagging notification
ODI Pharma AB (“ODI Pharma”) has been informed that Mr. Niclas Kappelin has acquired 20’000 shares in ODI Pharma and exceeded the...
